歡迎來到上海通蔚!

021-54845833/15800441009

品質(zhì)保證 · 通蔚試劑

當(dāng)前位置: 首頁 > 科研產(chǎn)品 > 科研抗體 > 一抗 > 兔抗ZC3H7A多克隆抗體

產(chǎn)品中心

  • 兔抗ZC3H7A多克隆抗體

    規(guī)格:
    數(shù)量:

    購(gòu)買數(shù)量

    價(jià)格:
    • 品牌 : 通蔚生物
    • 目錄號(hào) : TW5205
    • 應(yīng)用 : 僅限于科研使用
    • 保存條件 : 低溫保存
    • 貨期 : 現(xiàn)貨
    • 商品庫(kù)存:40
  • 商品詳情
  • 參考文獻(xiàn)
  • 說明書下載
  • 商品評(píng)論0
  • 相關(guān)產(chǎn)品

中文名稱:兔抗ZC3H7A多克隆抗體

英文名稱: Anti-ZC3H7A rabbit polyclonal antibody

別      名: zinc finger CCCH-type containing 7A; ZC3H7; HSPC055; ZC3HDC7

相關(guān)類別: 一抗

儲(chǔ)       存: 冷凍(-20℃)

宿       主: Rabbit

抗       原: ZC3H7A

反應(yīng)種屬: Human

標(biāo)  記   物: Unconjugate

克隆類型: rabbit polyclonal

技術(shù)規(guī)格

Background:

The zinc finger CCCH domain-containing protein 7A (ZC3H7A), also known as ZC3H7, HSPC055 or ZC3HDC7, is a 971 amino acid protein that contains a C3H1-type zinc finger domain, three C3H1-type zinc fingers and three TPR repeats. Belonging to the ZC3H12 family, ZC3H7A localizes to the nucleus. Existing as two alternatively spliced isoforms, ZC3H7A is encoded by a gene located on human chromosome 16p13.13. Chromosome 16 makes up nearly 3% of human cellular DNA and is associated with a variety of genetic disorders. The GAN gene is located on chromosome 16 and, with mutation, may lead to giant axonal neuropathy, a nervous system disorder characterized by increasing malfunction with growth. The rare disorder Rubinstein-Taybi syndrome is also associated with chromosome 16, though through the CREBBP gene which encodes a critical CREB binding protein. Signs of Rubinstein-Taybi include mental retardation and predisposition to tumor growth and white blood cell neoplasias. Crohn's disease is a gastrointestinal inflammatory condition associated with chromosome 16 through the NOD2 gene.

Applications:

ELISA, IHC

Name of antibody:

ZC3H7A

Immunogen:

Fusion protein of human ZC3H7A

Full name:

zinc finger CCCH-type containing 7A

Synonyms:

ZC3H7; HSPC055; ZC3HDC7

SwissProt:

Q8IWR0

ELISA Recommended dilution:

5000-10000

IHC positive control:

Human liver cancer and Human cervical cancer

IHC Recommend dilution:

50-300